Detalles de la búsqueda
1.
Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
Cancer Res
; 66(18): 9290-8, 2006 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16982774
2.
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
Cancer Res
; 66(9): 4943-51, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16651452
3.
Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96.
Cancer Res
; 65(9): 3942-9, 2005 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15867395
4.
Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides.
Clin Cancer Res
; 18(23): 6485-96, 2012 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23032742
5.
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.
Clin Cancer Res
; 16(3): 800-13, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20103663
6.
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients.
Cancer Immunol Immunother
; 55(8): 958-68, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16215718
7.
Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
J Immunol
; 172(9): 5363-70, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15100276
Resultados
1 -
7
de 7
1
Próxima >
>>